Ibrahim Yakoub‐Agha

Research interests

Publications

• Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

  Blood · 2023 · https://doi.org/10.1182/blood.2023020578

• Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  Bone Marrow Transplantation · 2022 · https://doi.org/10.1038/s41409-022-01691-w

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.12.003

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2024850

• Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00591-x

• Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

  Haematologica · 2019 · https://doi.org/10.3324/haematol.2019.229781

• Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

  Bone Marrow Transplantation · 2019 · https://doi.org/10.1038/s41409-019-0516-2

• Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

  Blood · 2017 · https://doi.org/10.1182/blood-2016-06-724500

• Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.130

• Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

  Bone Marrow Transplantation · 2015 · https://doi.org/10.1038/bmt.2015.52

• Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.55.2018

• Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

  Blood · 2007 · https://doi.org/10.1182/blood-2006-08-040410

• Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

  The Lancet · 2007 · https://doi.org/10.1016/s0140-6736(07)61537-2

Current projects

No projects listed.